Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (2,423)	$ (8,542)
Investing Activities
Capital expenditures	(6,718)	(14,628)
Proceeds from the sale of assets	1,474	140
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash used in investing activities	(5,244)	(14,488)
Financing Activities
Borrowings under ABL facilities	132,789	135,731
Payments under ABL facilities	(145,649)	(110,653)
Proceeds from promissory note	27,500	0
Financing fees	(3,203)	0
Borrowings from affiliates	0	0
Repayments to affiliates		0
Net cash provided by financing activities	11,437	25,078
Effect of exchange rate changes on cash and cash equivalents	14	(70)
Net increase (decrease) in cash and cash equivalents	3,784	1,978
Cash and cash equivalents at beginning of period	9,394	5,963
Cash and cash equivalents at end of period	13,178	7,941
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(21,721)	(31,035)
Investing Activities
Capital expenditures	(4,715)	(13,160)
Proceeds from the sale of assets	1,470	138
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	2,000
Net cash used in investing activities	(3,245)	(11,022)
Financing Activities
Borrowings under ABL facilities	72,500	71,700
Payments under ABL facilities	(89,900)	(54,700)
Proceeds from promissory note	20,000
Financing fees	(3,193)
Borrowings from affiliates	26,489	40,418
Repayments to affiliates		(14,000)
Net cash provided by financing activities	25,896	43,418
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	930	1,361
Cash and cash equivalents at beginning of period	8,356	5,933
Cash and cash equivalents at end of period	9,286	7,294
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash used in investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	19,164	15,531
Investing Activities
Capital expenditures	(127)	(113)
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	(19,189)	(15,418)
Receipts on loans to affiliates	0	0
Net cash used in investing activities	(19,316)	(15,531)
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	(152)	0
Cash and cash equivalents at beginning of period	152	0
Cash and cash equivalents at end of period	0	0
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	134	6,962
Investing Activities
Capital expenditures	(1,876)	(1,355)
Proceeds from the sale of assets	4	2
Payments on loans to affiliates	0	(25,000)
Receipts on loans to affiliates	(7,300)	14,000
Net cash used in investing activities	(9,172)	(12,353)
Financing Activities
Borrowings under ABL facilities	60,289	64,031
Payments under ABL facilities	(55,749)	(55,953)
Proceeds from promissory note	7,500
Financing fees	(10)
Borrowings from affiliates	0	0
Repayments to affiliates		(2,000)
Net cash provided by financing activities	12,030	6,078
Effect of exchange rate changes on cash and cash equivalents	14	(70)
Net increase (decrease) in cash and cash equivalents	3,006	617
Cash and cash equivalents at beginning of period	886	30
Cash and cash equivalents at end of period	3,892	647
Reclassification/ Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	19,189	40,418
Receipts on loans to affiliates	7,300	(16,000)
Net cash used in investing activities	26,489	24,418
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	(26,489)	(40,418)
Repayments to affiliates		16,000
Net cash provided by financing activities	(26,489)	(24,418)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0